CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
about
Metabolic Regulation in Mitochondria and Drug Resistance.Mitochondrial DNA Methylation and Related Disease.Mitochondrial DNA in Telocytes.Mitochondrial DNA in Lung Cancer.How Far Can Mitochondrial DNA Drive the Disease?Single-cell CRISPR screening in drug resistance.Understanding toxicology: mechanisms and applications.
P2860
Q46609962-CE7E8103-2374-4347-91D0-BED9C22C1A38Q49605126-2194E0E2-C2B9-4A30-AC73-C75EC804523AQ49605157-AD01E961-091B-4411-BE15-BE1567AE85F7Q49605186-08193D88-AC17-42FA-ADDA-0D7182200A2FQ49605194-6F37DB2D-BD14-4D9A-9AE5-5736AAEBAAF7Q52427700-50CAF6DC-E2F6-4375-B34C-DC9238C29707Q54683072-3048D7C0-930B-4F68-B34D-A3140C42F121
P2860
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@en
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@nl
type
label
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@en
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@nl
prefLabel
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@en
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@nl
P2860
P1476
CBT profiles of cabozantinib approved for advanced renal cell carcinomas.
@en
P2093
Xiangdong Wang
P2860
P2888
P304
P356
10.1007/S10565-016-9349-6
P577
2016-07-06T00:00:00Z